Expression and clinical significance of thrombospondin-1 and plasminogen activator inhibitor-1 in patients with mesangial proliferative glomerulonephritis.
Pan C, Zhou C, Shan A, Chen N.
Ann Palliat Med. 2020 Sep;9(5):3187-3193. doi: 10.21037/apm-20-1291. Epub 2020 Aug 31.
Mesangial proliferative glomerulonephritis with or without IgA deposits: the morphological characters in psoriasis vulgaris.
Jiao Y, Xu H, Li H, Li X.
Nephron Clin Pract. 2008;108(3):c221-5. doi: 10.1159/000119716. Epub 2008 Mar 7.
Promising response of proliferative glomerulonephritis with monoclonal IgG deposits to low-dose daratumumab: a case report.
Xu H, Huang Y, Dong L, Yu H, Lin B.
Front Med (Lausanne). 2024 Jul 24;11:1360979. doi: 10.3389/fmed.2024.1360979. eCollection 2024.
The role of the mesangial cell in proliferative glomerulonephritis.
Davison AM, Thomson D, MacDonald MK, Uttley WS, Robson JS.
J Clin Pathol. 1973 Mar;26(3):198-208. doi: 10.1136/jcp.26.3.198.
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits in a young woman: A case report.
Xu ZG, Li WL, Wang X, Zhang SY, Zhang YW, Wei X, Li CD, Zeng P, Luan SD.
World J Clin Cases. 2021 Apr 6;9(10):2357-2366. doi: 10.12998/wjcc.v9.i10.2357.
Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
Ohtake T, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Kobayashi S.
Hypertens Res. 2008 Mar;31(3):387-94. doi: 10.1291/hypres.31.387.
Multicentric Castleman's disease with renal amyloidosis and mesangial proliferative glomerulonephritis: a case report.
Tan Z, Wang L, Wang C, Gao L, Yang Y.
Int J Clin Exp Med. 2015 Feb 15;8(2):2966-73. eCollection 2015.
Mesangial proliferative glomerulonephritis associated with progressive amyloid deposition in hamsters experimentally infected with Leishmania donovani.
Oliveira AV, Roque-Barreira MC, Sartori A, Campos-Neto A, Rossi MA.
Am J Pathol. 1985 Aug;120(2):256-62.
Diffuse proliferative glomerulonephritis--how many types?
Pound SE, MacDonald MK, Thomson D.
Histopathology. 1987 Mar;11(3):227-43. doi: 10.1111/j.1365-2559.1987.tb02629.x.
Clinicopathologic features, outcome, and therapeutic interventions in four children with isolated C3 mesangial proliferative glomerulonephritis.
Yagi K, Yanagida H, Sugimoto K, Kuwajima H, Tabata N, Morita K, Okada M, Takemura T.
Pediatr Nephrol. 2005 Sep;20(9):1273-8. doi: 10.1007/s00467-005-1919-4. Epub 2005 Jun 10.
